Eastman Chemical EVP granted options and RSUs

Eastman Chemical Company executive Brian Travis Smith received new equity awards.

Rhea-AI Filing Summary

Eastman Chemical Company executive Brian Travis Smith received new equity awards. On February 24, 2026, he was granted 53,157 employee stock options with an exercise price of $0.0000 per option. One-third of these options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.

He was also granted 7,313 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Eastman Chemical common stock, and these units will vest and pay out in unrestricted shares on the third anniversary of the grant date, February 24, 2029, subject to continued employment.

Insider Trade Summary

Grant/Award: 60,470 shares

Grant/Award 2 txns

Insider SMITH BRIAN TRAVIS

Role EVP, AFP, Mfg., WWEC & HSE

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	53,157	$0.00	$0.00
Grant/Award	Restricted Stock Units	7,313	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 53,157 contracts (Direct); Restricted Stock Units — 7,313 contracts (Direct)

Footnotes (3)

1. F1. One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.
2. F2. Each restricted stock unit represents a contingent right to receive one share of issuer common stock.
3. F3. The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Eastman Chemical (EMN) executive Brian Travis Smith receive in this Form 4?

Brian Travis Smith received equity-based compensation from Eastman Chemical. He was granted 53,157 employee stock options and 7,313 restricted stock units, both dated February 24, 2026, as part of his executive compensation package, with future vesting conditions attached.

How many stock options were granted to the Eastman Chemical (EMN) executive?

Brian Travis Smith received 53,157 employee stock options. These options carry an exercise right that becomes available over time. One-third of the options become exercisable in each of three years: 2027, 2028, and 2029, according to the vesting schedule disclosed.

What are the vesting terms for the Eastman Chemical (EMN) stock options?

The 53,157 stock options vest in three equal installments. One-third becomes exercisable on February 24, 2027, another third on February 24, 2028, and the final third on February 24, 2029, aligning the award with multi-year executive retention incentives.

How many restricted stock units did Eastman Chemical (EMN) grant to the executive?

Eastman Chemical granted 7,313 restricted stock units to Brian Travis Smith. Each unit represents a contingent right to one common share, providing future share-based compensation rather than immediate stock ownership or cash, subject to the vesting conditions described.

When do the Eastman Chemical (EMN) restricted stock units vest and pay out?

The 7,313 restricted stock units vest and pay out on the third anniversary of the grant date. On February 24, 2029, they convert into unrestricted shares of Eastman Chemical common stock, provided the executive remains employed through that date.

Does the Eastman Chemical (EMN) Form 4 reflect a stock purchase or sale?

The Form 4 reflects grants of equity awards, not open-market buying or selling. The transactions are coded as acquisitions of derivative securities (stock options and restricted stock units) awarded to the executive as compensation, at a reported price of $0.0000 per unit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 04:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SMITH BRIAN TRAVIS

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, AFP, Mfg., WWEC & HSE

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$77.12	02/24/2026		A		53,157		02/24/2027(1)	02/23/2036	Common Stock	53,157	$0	53,157	D
Restricted Stock Units	(2)	02/24/2026		A		7,313		(3)	(3)	Common Stock	7,313	$0	7,313	D

Explanation of Responses:

1. One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.

2. Each restricted stock unit represents a contingent right to receive one share of issuer common stock.

3. The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Brian Travis Smith	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.